package_date,short_name,bc_id,ncit_code,parent_bc_id,bc_categories,synonyms,result_scales,definition,system,system_name,code,dec_id,ncit_dec_code,dec_label,data_type,example_set
2025-12-16,Activated Partial Thromboplastin Time,C38462,C38462,C81959,Laboratory Tests;Chemistry Tests;Hematology Tests;Coagulation Study;Blood Protein Measurements;Factor III Measurements,APTT,Quantitative,A measurement of the length of time that it takes for clotting to occur when activating reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.,,,,C93566,C93566,Fasting Status Indicator,boolean,
2025-12-16,Activated Partial Thromboplastin Time,C38462,C38462,C81959,Laboratory Tests;Chemistry Tests;Hematology Tests;Coagulation Study;Blood Protein Measurements;Factor III Measurements,APTT,Quantitative,A measurement of the length of time that it takes for clotting to occur when activating reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.,,,,C70713,C70713,Biospecimen Type,string,Blood;Platelet Poor Plasma
2025-12-16,Activated Partial Thromboplastin Time,C38462,C38462,C81959,Laboratory Tests;Chemistry Tests;Hematology Tests;Coagulation Study;Blood Protein Measurements;Factor III Measurements,APTT,Quantitative,A measurement of the length of time that it takes for clotting to occur when activating reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.,,,,C42574,C42574,Unit of Time,string,Seconds
2025-12-16,Activated Partial Thromboplastin Time,C38462,C38462,C81959,Laboratory Tests;Chemistry Tests;Hematology Tests;Coagulation Study;Blood Protein Measurements;Factor III Measurements,APTT,Quantitative,A measurement of the length of time that it takes for clotting to occur when activating reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.,,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Activated Partial Thromboplastin Time,C38462,C38462,C81959,Laboratory Tests;Chemistry Tests;Hematology Tests;Coagulation Study;Blood Protein Measurements;Factor III Measurements,APTT,Quantitative,A measurement of the length of time that it takes for clotting to occur when activating reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture.,,,,C70856,C70856,Observation Result,integer,
2025-12-16,Acute Physiology and Chronic Health Evaluation II Clinical Classification,C121005,C121005,C118969,QRS;Clinical or Research Assessment Classification;Acute Physiology and Chronic Health Evaluation II Clinical Classification;APACHE II;APCH1,APACHE II,,"A standardized rating scale developed by Knaus et al in 1985, which is a classification system used to measure severity of disease. This instrument uses a point score system based on physiological measurements, age and previous health status.",,,,C82525,C82525,Test Occurrence,string,N;Y
2025-12-16,Acute Physiology and Chronic Health Evaluation II Clinical Classification,C121005,C121005,C118969,QRS;Clinical or Research Assessment Classification;Acute Physiology and Chronic Health Evaluation II Clinical Classification;APACHE II;APCH1,APACHE II,,"A standardized rating scale developed by Knaus et al in 1985, which is a classification system used to measure severity of disease. This instrument uses a point score system based on physiological measurements, age and previous health status.",,,,C25372,C25372,Category,string,APACHE II
2025-12-16,Acute Physiology and Chronic Health Evaluation II Clinical Classification,C121005,C121005,C118969,QRS;Clinical or Research Assessment Classification;Acute Physiology and Chronic Health Evaluation II Clinical Classification;APACHE II;APCH1,APACHE II,,"A standardized rating scale developed by Knaus et al in 1985, which is a classification system used to measure severity of disease. This instrument uses a point score system based on physiological measurements, age and previous health status.",,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Allergen-induced IgG Antibody Measurement,C187777,C187777,C182150,Laboratory Tests;Immunogenicity Specimen Assessments;Immunoglobulin G Measurements;Allergen-induced Antibody Measurements,ARIGGAB;Allergen-induced IgG Antibody,Quantitative;Ordinal,The determination of the amount of allergen-induced IgG antibody in a sample.,,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Allergen-induced IgG Antibody Measurement,C187777,C187777,C182150,Laboratory Tests;Immunogenicity Specimen Assessments;Immunoglobulin G Measurements;Allergen-induced Antibody Measurements,ARIGGAB;Allergen-induced IgG Antibody,Quantitative;Ordinal,The determination of the amount of allergen-induced IgG antibody in a sample.,,,,C82535,C82535,Test Method,string,Immunoassay;Enzyme-linked Immunosorbent Assay
2025-12-16,Allergen-induced IgG Antibody Measurement,C187777,C187777,C182150,Laboratory Tests;Immunogenicity Specimen Assessments;Immunoglobulin G Measurements;Allergen-induced Antibody Measurements,ARIGGAB;Allergen-induced IgG Antibody,Quantitative;Ordinal,The determination of the amount of allergen-induced IgG antibody in a sample.,,,,C48207,C48207,Unit of Concentration,string,IU/mL;ng/mL;ng/dL;U/mL
2025-12-16,Allergen-induced IgG Antibody Measurement,C187777,C187777,C182150,Laboratory Tests;Immunogenicity Specimen Assessments;Immunoglobulin G Measurements;Allergen-induced Antibody Measurements,ARIGGAB;Allergen-induced IgG Antibody,Quantitative;Ordinal,The determination of the amount of allergen-induced IgG antibody in a sample.,,,,C70856,C70856,Observation Result,string,0 Absent or undetectable allergen specific IgE;1 Low level of allergen specific IgE;2 Moderate level of allergen specific IgE;3 High level of allergen specific IgE;4 Very high level of allergen specific IgE;5 Ultra high level of allergen specific IgE;6 Extremely high level of allergen specific IgE
2025-12-16,Allergen-induced IgG Antibody Measurement,C187777,C187777,C182150,Laboratory Tests;Immunogenicity Specimen Assessments;Immunoglobulin G Measurements;Allergen-induced Antibody Measurements,ARIGGAB;Allergen-induced IgG Antibody,Quantitative;Ordinal,The determination of the amount of allergen-induced IgG antibody in a sample.,,,,C46126,C46126,Ordinal Position,integer,0;1;2;3;4;5;6
2025-12-16,Allergen-induced IgG Antibody Measurement,C187777,C187777,C182150,Laboratory Tests;Immunogenicity Specimen Assessments;Immunoglobulin G Measurements;Allergen-induced Antibody Measurements,ARIGGAB;Allergen-induced IgG Antibody,Quantitative;Ordinal,The determination of the amount of allergen-induced IgG antibody in a sample.,,,,C117062,C117062,"Measurement, Test or Examination Detail",string,Radioallergosorbent test
2025-12-16,Allergen-induced IgG Antibody Measurement,C187777,C187777,C182150,Laboratory Tests;Immunogenicity Specimen Assessments;Immunoglobulin G Measurements;Allergen-induced Antibody Measurements,ARIGGAB;Allergen-induced IgG Antibody,Quantitative;Ordinal,The determination of the amount of allergen-induced IgG antibody in a sample.,,,,C218437,C218437,Immunogenicity Specimen Test Operational Objective,string,Screen;Confirm;Quantify;Overall Subject Status
2025-12-16,Allergen-induced IgG Antibody Measurement,C187777,C187777,C182150,Laboratory Tests;Immunogenicity Specimen Assessments;Immunoglobulin G Measurements;Allergen-induced Antibody Measurements,ARIGGAB;Allergen-induced IgG Antibody,Quantitative;Ordinal,The determination of the amount of allergen-induced IgG antibody in a sample.,,,,C42647,C42647,Binder Excipient,string,American Cockroach Antigen;Animal Mix Antigens;Bee Mix Venom Antigens;Bermuda Grass Pollen;Cat Dander Antigen;American House Dust Mite Antigen;European House Dust Mite Antigen;Dairy Mix Antigens;Dog Dander Antigen;English Plantain Pollen;German Cockroach Antigen;Gliadin Antigen;Grass Mix Pollens;Chemical Mix Antigens;Keyhole Limpet Hemocyanin;Mold Mix Antigens;Nut Mix Antigens;Orchard Grass Pollen;Shellfish Mix Antigens;Silver Birch Pollen;Timothy Grass Pollen;Tree Mix Pollens;Weed Mix Pollens;Western Ragweed Pollen;White Elm Pollen;Aspergillus Fumigatus;Alternaria Alternata;Penicillium Chrysogenum;Mucor Racemosus
2025-12-16,Allergen-induced IgG Antibody Measurement,C187777,C187777,C182150,Laboratory Tests;Immunogenicity Specimen Assessments;Immunoglobulin G Measurements;Allergen-induced Antibody Measurements,ARIGGAB;Allergen-induced IgG Antibody,Quantitative;Ordinal,The determination of the amount of allergen-induced IgG antibody in a sample.,,,,C70713,C70713,Biospecimen Type,string,Serum;Plasma
2025-12-16,Allergen-induced IgG Antibody Measurement,C187777,C187777,C182150,Laboratory Tests;Immunogenicity Specimen Assessments;Immunoglobulin G Measurements;Allergen-induced Antibody Measurements,ARIGGAB;Allergen-induced IgG Antibody,Quantitative;Ordinal,The determination of the amount of allergen-induced IgG antibody in a sample.,,,,C25692,C25692,Subcategory,string,
2025-12-16,Allergen-induced IgG Antibody Measurement,C187777,C187777,C182150,Laboratory Tests;Immunogenicity Specimen Assessments;Immunoglobulin G Measurements;Allergen-induced Antibody Measurements,ARIGGAB;Allergen-induced IgG Antibody,Quantitative;Ordinal,The determination of the amount of allergen-induced IgG antibody in a sample.,,,,C25372,C25372,Category,string,
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C83199,C83199,Adverse Event Concomitant Treatment,boolean,Y;N
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C49489,C49489,Adverse Event Outcome,string,Fatal;Not Recovered/Not Resolved;Recovered/Resolved With Sequelae;Recovered/Resolved;Recovering/Resolving;Unknown
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C83208,C83208,Adverse Event Pattern,string,Intermittent;Continuous;Single Event
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C83210,C83210,Adverse Event Relationship to Non Study Treatment,string,Not related;Unlikely Related;Possibly Related;Related
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C41358,C41358,Adverse Event Attribution to Product or Procedure,string,Not related;Unlikely Related;Possibly Related;Related
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C83109,C83109,Other Actions taken in Response to Adverse Event,string,Treatment Unblinded;Ptrimary Care Physician Notified
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C53252,C53252,Seriousness of Adverse Event,boolean,Y;N
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C53253,C53253,Severity of Adverse Event,string,Mild;Moderate;Severe
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C83212,C83212,Adverse Event Subcategory,string,
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C87840,C87840,Adverse Event Pre-specified,boolean,Y;N
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C78541,C78541,Adverse Event Verbatim Description,string,
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C83205,C83205,Adverse Event Location,string,
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C83013,C83013,Adverse Event Action Taken with Study Treatment,string,Drug Withdrawn;Dose Reduced;Dose Increased;Dose Not Changed;Unknown
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C83344,C83344,Adverse Event Dictionary Derived Term,string,
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C78605,C78605,Adverse Event Toxicity Grade,string,0;1;2;3;4;5
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C83053,C83053,Adverse Event Associated with Serious Medical Event,boolean,Y;N
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C83214,C83214,Adverse Event Occurred with Overdose,boolean,Y;N
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C84266,C84266,Life Threatening Adverse Event,boolean,Y;N
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C83052,C83052,Adverse Event associated with Hospitalization,boolean,Y;N
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C48275,C48275,Death Related to Adverse Event,boolean,Y;N
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C83211,C83211,Adverse Event Involves Cancer,boolean,Y;N
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C83215,C83215,Adverse Event Start Date Time,datetime,
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C113380,C113380,Disabling Adverse Event,boolean,Y;N
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C83201,C83201,Adverse Event End Date Time,datetime,
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C83198,C83198,Adverse Event Category,string,
2025-12-16,Anticipated Adverse Event [RETIRED],C156629,C156629,C41331,Events;Reported Events;Adverse Events,Adverse Event;Prespecified Adverse Event,Nominal,An adverse event that is reasonably expected and/or listed in the clinical protocol or other study-related document. [RETIRED],,,,C83117,C83117,Adverse Event Seriousness Due to Congenital Anomaly,boolean,Y;N
2025-12-16,Arterial Blood Gas Measurement,C71252,C71252,,Laboratory Tests;Chemistry Tests,ABG,,"Measures the acidity (pH) and the levels of oxygen, carbon dioxide, and bicarbonate in the blood.",,,,,,,,
2025-12-16,Blood Cell Count Ratio Measurement,C67208,C67208,C28133,Laboratory Tests;Hematology Tests;Blood Cell Counts;Blood Cell Count Ratio Measurements,,,The determination of the ratio of one blood cell component to another in a blood sample. The measurement may be expressed as either a ratio or a percentage.,,,,,,,,
2025-12-16,Body Frame Size,C49680,C49680,,Vital Signs;Body Measurements,Frame Size,Ordinal,"The categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow.",,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Body Frame Size,C49680,C49680,,Vital Signs;Body Measurements,Frame Size,Ordinal,"The categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow.",,,,C70856,C70856,Observation Result,decimal,
2025-12-16,Choriogonadotropin Beta Measurement,C64851,C64851,C147128,Laboratory Tests;Chemistry Tests;Hormone Measurements;Choriogonadotropin Measurements;HCG Measurements,beta-hCG;Choriogonadotropin Beta;Pregnancy Test;HCG,Quantitative;Ordinal,A determination of the presence of Choriogonadotropin Beta protein.,,,,C70856,C70856,Observation Result,string,Positive;Negative;Reactive;Indeterminate;Nonreactive;1+;2+;3+
2025-12-16,Choriogonadotropin Beta Measurement,C64851,C64851,C147128,Laboratory Tests;Chemistry Tests;Hormone Measurements;Choriogonadotropin Measurements;HCG Measurements,beta-hCG;Choriogonadotropin Beta;Pregnancy Test;HCG,Quantitative;Ordinal,A determination of the presence of Choriogonadotropin Beta protein.,,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Choriogonadotropin Beta Measurement,C64851,C64851,C147128,Laboratory Tests;Chemistry Tests;Hormone Measurements;Choriogonadotropin Measurements;HCG Measurements,beta-hCG;Choriogonadotropin Beta;Pregnancy Test;HCG,Quantitative;Ordinal,A determination of the presence of Choriogonadotropin Beta protein.,,,,C70713,C70713,Biospecimen Type,string,Serum;Plasma;Urine
2025-12-16,Coombs Test,C25163,C25163,,Laboratory Tests;Hematology Tests;Immunohematology Tests;Autoantibody Measurements;Antibody Measurements;Immunology Tests,Antiglobulin test;Coombs,Ordinal;Quantitative,"A hemagglutination test using anti-human globulin (antiglobulin, Coombs reagent) to detect antibodies that react with a subject's red blood cells. The test takes two forms: the direct test is used to diagnose autoimmune hemolytic anemia; the indirect test is used for prenatal Rhesus factor compatibility, blood and tissue typing, and transplant cross-matching.",,,,,,,,
2025-12-16,Creatine Kinase Measurement,C64489,C64489,C64430,Laboratory Tests;Chemistry Tests;Protein or Enzyme Type Measurements,CK;CPK;Creatine Kinase;Creatine Phosphokinase,Quantitative;Ordinal,A quantitative measurement of the amount of creatine kinase present in a sample.,,,,C70856,C70856,Observation Result,string,
2025-12-16,Creatine Kinase Measurement,C64489,C64489,C64430,Laboratory Tests;Chemistry Tests;Protein or Enzyme Type Measurements,CK;CPK;Creatine Kinase;Creatine Phosphokinase,Quantitative;Ordinal,A quantitative measurement of the amount of creatine kinase present in a sample.,,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Creatine Kinase Measurement,C64489,C64489,C64430,Laboratory Tests;Chemistry Tests;Protein or Enzyme Type Measurements,CK;CPK;Creatine Kinase;Creatine Phosphokinase,Quantitative;Ordinal,A quantitative measurement of the amount of creatine kinase present in a sample.,,,,C93566,C93566,Fasting Status Indicator,boolean,
2025-12-16,Creatine Kinase Measurement,C64489,C64489,C64430,Laboratory Tests;Chemistry Tests;Protein or Enzyme Type Measurements,CK;CPK;Creatine Kinase;Creatine Phosphokinase,Quantitative;Ordinal,A quantitative measurement of the amount of creatine kinase present in a sample.,,,,C48207,C48207,Unit of Concentration,string,U/L;IU/L;ukat/L;nkat/L;ug/L
2025-12-16,Creatine Kinase Measurement,C64489,C64489,C64430,Laboratory Tests;Chemistry Tests;Protein or Enzyme Type Measurements,CK;CPK;Creatine Kinase;Creatine Phosphokinase,Quantitative;Ordinal,A quantitative measurement of the amount of creatine kinase present in a sample.,,,,C70713,C70713,Biospecimen Type,string,Blood;Plasma;Serum;Cerebral Spinal Fluid;Body Fluid
2025-12-16,Diagnostic Criteria,C117960,C117960,C25466,Clinical Trial Attribute;Trial Summary,DXCRIT,Nominal,A standard from which a judgment concerning a medical diagnosis can be established.,,,,C83445,C83445,Trial Summary Parameter Code,string,DXCRIT
2025-12-16,Diagnostic Criteria,C117960,C117960,C25466,Clinical Trial Attribute;Trial Summary,DXCRIT,Nominal,A standard from which a judgment concerning a medical diagnosis can be established.,,,,C83447,C83447,Trial Summary Parameter Value,string,
2025-12-16,Diagnostic Criteria,C117960,C117960,C25466,Clinical Trial Attribute;Trial Summary,DXCRIT,Nominal,A standard from which a judgment concerning a medical diagnosis can be established.,,,,C49691,C49691,Trial Summary Parameter,string,Diagnostic Criteria
2025-12-16,Diastolic Blood Pressure,C25299,C25299,C54706,Vital Signs;Blood Pressure,DIABP,Quantitative,The minimum pressure exerted into the systemic arterial circulation during cardiac ventricular relaxation and filling.,http://loinc.org/,LOINC,8462-4,C13717,C13717,Anatomic Site,string,Arm;Artery;Calf;Forearm;Thigh;Vein
2025-12-16,Diastolic Blood Pressure,C25299,C25299,C54706,Vital Signs;Blood Pressure,DIABP,Quantitative,The minimum pressure exerted into the systemic arterial circulation during cardiac ventricular relaxation and filling.,http://loinc.org/,LOINC,8462-4,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Diastolic Blood Pressure,C25299,C25299,C54706,Vital Signs;Blood Pressure,DIABP,Quantitative,The minimum pressure exerted into the systemic arterial circulation during cardiac ventricular relaxation and filling.,http://loinc.org/,LOINC,8462-4,C49669,C49669,Unit of Pressure,string,cmHg;mmHG;Pascal
2025-12-16,Diastolic Blood Pressure,C25299,C25299,C54706,Vital Signs;Blood Pressure,DIABP,Quantitative,The minimum pressure exerted into the systemic arterial circulation during cardiac ventricular relaxation and filling.,http://loinc.org/,LOINC,8462-4,C70856,C70856,Observation Result,decimal,
2025-12-16,Diastolic Blood Pressure,C25299,C25299,C54706,Vital Signs;Blood Pressure,DIABP,Quantitative,The minimum pressure exerted into the systemic arterial circulation during cardiac ventricular relaxation and filling.,http://loinc.org/,LOINC,8462-4,C62164,C62164,Body Position,string,"Decubitus;Fowlers;Lateral Decubitus;Left Lateral Decubitus;Prone;Reverse Trendelenburg;Right Lateral Decubitus;Semi-Fowlers;Semi-Recumbent;Sitting;Sitting, Legs Dependent;Sling;Standing;Standing, Bent Forward;Supine;Trendelenburg;Unconstrained"
2025-12-16,Diastolic Blood Pressure,C25299,C25299,C54706,Vital Signs;Blood Pressure,DIABP,Quantitative,The minimum pressure exerted into the systemic arterial circulation during cardiac ventricular relaxation and filling.,http://loinc.org/,LOINC,8462-4,C25185,C25185,Laterality,string,Left;Right
2025-12-16,Diastolic Blood Pressure,C25299,C25299,C54706,Vital Signs;Blood Pressure,DIABP,Quantitative,The minimum pressure exerted into the systemic arterial circulation during cardiac ventricular relaxation and filling.,http://loinc.org/,LOINC,8462-4,C82535,C82535,Test Method,string,Auscultation automatic;Auscultation manual;Cuff-manual palpated;Doppler;Oscillometry;Arterial line;Venous line;Continuous noninvasive arterial pressure (CNAP)
2025-12-16,Direct Antiglobulin Test,C81974,C81974,C25163,Laboratory Tests;Hematology Tests;Immunohematology Tests;Autoantibody Measurements;Antibody Measurements;Immunology Tests;Coombs Tests,"ANGLOBDR;Antiglobulin Test Polyspecific, Direct;Antiglobulin Test, Direct;DAT;Direct Anti-human Globulin Test;Direct Antiglobulin Test;Direct Coombs Test",Ordinal,A measurement of the antibody or complement-coated erythrocytes in a blood specimen in vivo.,,,,C70856,C70856,Observation Result,string,Positive;Negative;0;1+;2+;3+;4+
2025-12-16,Direct Antiglobulin Test,C81974,C81974,C25163,Laboratory Tests;Hematology Tests;Immunohematology Tests;Autoantibody Measurements;Antibody Measurements;Immunology Tests;Coombs Tests,"ANGLOBDR;Antiglobulin Test Polyspecific, Direct;Antiglobulin Test, Direct;DAT;Direct Anti-human Globulin Test;Direct Antiglobulin Test;Direct Coombs Test",Ordinal,A measurement of the antibody or complement-coated erythrocytes in a blood specimen in vivo.,,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Direct Antiglobulin Test,C81974,C81974,C25163,Laboratory Tests;Hematology Tests;Immunohematology Tests;Autoantibody Measurements;Antibody Measurements;Immunology Tests;Coombs Tests,"ANGLOBDR;Antiglobulin Test Polyspecific, Direct;Antiglobulin Test, Direct;DAT;Direct Anti-human Globulin Test;Direct Antiglobulin Test;Direct Coombs Test",Ordinal,A measurement of the antibody or complement-coated erythrocytes in a blood specimen in vivo.,,,,C93566,C93566,Fasting Status Indicator,boolean,
2025-12-16,Direct Antiglobulin Test,C81974,C81974,C25163,Laboratory Tests;Hematology Tests;Immunohematology Tests;Autoantibody Measurements;Antibody Measurements;Immunology Tests;Coombs Tests,"ANGLOBDR;Antiglobulin Test Polyspecific, Direct;Antiglobulin Test, Direct;DAT;Direct Anti-human Globulin Test;Direct Antiglobulin Test;Direct Coombs Test",Ordinal,A measurement of the antibody or complement-coated erythrocytes in a blood specimen in vivo.,,,,C70713,C70713,Biospecimen Type,string,Red Blood Cells
2025-12-16,Direct Bilirubin Measurement,C64481,C64481,C74954,Laboratory Tests;Chemistry Tests;Liver Function Tests,BILDIR;Conjugated Bilirubin + Albumin-Bound Bilirubin;Conjugated Bilirubin + Delta Bilirubin;Direct Bilirubin,Quantitative;Ordinal,The bilirubin is bound to glucuronide to form conjugated bilirubin (direct bilirubin). Direct Bilirubin measurement is accomplished by a colorimetric method. Direct Bilirubin in biological fluids reacts with sulfanilic acid at acidic pH to produce a red colored complex. The optical density of produced color has a direct relationship with Direct Bilirubin concentration in the solution.,,,,C93566,C93566,Fasting Status Indicator,boolean,
2025-12-16,Direct Bilirubin Measurement,C64481,C64481,C74954,Laboratory Tests;Chemistry Tests;Liver Function Tests,BILDIR;Conjugated Bilirubin + Albumin-Bound Bilirubin;Conjugated Bilirubin + Delta Bilirubin;Direct Bilirubin,Quantitative;Ordinal,The bilirubin is bound to glucuronide to form conjugated bilirubin (direct bilirubin). Direct Bilirubin measurement is accomplished by a colorimetric method. Direct Bilirubin in biological fluids reacts with sulfanilic acid at acidic pH to produce a red colored complex. The optical density of produced color has a direct relationship with Direct Bilirubin concentration in the solution.,,,,C70856,C70856,Observation Result,string,
2025-12-16,Direct Bilirubin Measurement,C64481,C64481,C74954,Laboratory Tests;Chemistry Tests;Liver Function Tests,BILDIR;Conjugated Bilirubin + Albumin-Bound Bilirubin;Conjugated Bilirubin + Delta Bilirubin;Direct Bilirubin,Quantitative;Ordinal,The bilirubin is bound to glucuronide to form conjugated bilirubin (direct bilirubin). Direct Bilirubin measurement is accomplished by a colorimetric method. Direct Bilirubin in biological fluids reacts with sulfanilic acid at acidic pH to produce a red colored complex. The optical density of produced color has a direct relationship with Direct Bilirubin concentration in the solution.,,,,C48207,C48207,Unit of Concentration,string,umol/L;mg/dL;mg/L
2025-12-16,Direct Bilirubin Measurement,C64481,C64481,C74954,Laboratory Tests;Chemistry Tests;Liver Function Tests,BILDIR;Conjugated Bilirubin + Albumin-Bound Bilirubin;Conjugated Bilirubin + Delta Bilirubin;Direct Bilirubin,Quantitative;Ordinal,The bilirubin is bound to glucuronide to form conjugated bilirubin (direct bilirubin). Direct Bilirubin measurement is accomplished by a colorimetric method. Direct Bilirubin in biological fluids reacts with sulfanilic acid at acidic pH to produce a red colored complex. The optical density of produced color has a direct relationship with Direct Bilirubin concentration in the solution.,,,,C70713,C70713,Biospecimen Type,string,Plasma;Serum;Body Fluid
2025-12-16,Direct Bilirubin Measurement,C64481,C64481,C74954,Laboratory Tests;Chemistry Tests;Liver Function Tests,BILDIR;Conjugated Bilirubin + Albumin-Bound Bilirubin;Conjugated Bilirubin + Delta Bilirubin;Direct Bilirubin,Quantitative;Ordinal,The bilirubin is bound to glucuronide to form conjugated bilirubin (direct bilirubin). Direct Bilirubin measurement is accomplished by a colorimetric method. Direct Bilirubin in biological fluids reacts with sulfanilic acid at acidic pH to produce a red colored complex. The optical density of produced color has a direct relationship with Direct Bilirubin concentration in the solution.,,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Erythrocyte Count,C51946,C51946,C28133,Laboratory Tests;Hematology Tests;Blood Cell Counts,RBC;Red Blood Cells,Quantitative,The determination of the number of erythrocytes in a biospecimen.,,,,C67391,C67391,Unit of Number Concentration,string,
2025-12-16,Erythrocyte Count,C51946,C51946,C28133,Laboratory Tests;Hematology Tests;Blood Cell Counts,RBC;Red Blood Cells,Quantitative,The determination of the number of erythrocytes in a biospecimen.,,,,C70713,C70713,Biospecimen Type,string,Blood;Urine;Stool
2025-12-16,Erythrocyte Count,C51946,C51946,C28133,Laboratory Tests;Hematology Tests;Blood Cell Counts,RBC;Red Blood Cells,Quantitative,The determination of the number of erythrocytes in a biospecimen.,,,,C70856,C70856,Observation Result,decimal,
2025-12-16,Erythrocyte Count,C51946,C51946,C28133,Laboratory Tests;Hematology Tests;Blood Cell Counts,RBC;Red Blood Cells,Quantitative,The determination of the number of erythrocytes in a biospecimen.,,,,C82535,C82535,Test Method,string,
2025-12-16,Erythrocyte Count,C51946,C51946,C28133,Laboratory Tests;Hematology Tests;Blood Cell Counts,RBC;Red Blood Cells,Quantitative,The determination of the number of erythrocytes in a biospecimen.,,,,C93566,C93566,Fasting Status Indicator,boolean,
2025-12-16,Erythrocyte Count,C51946,C51946,C28133,Laboratory Tests;Hematology Tests;Blood Cell Counts,RBC;Red Blood Cells,Quantitative,The determination of the number of erythrocytes in a biospecimen.,,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Factor III Measurement,C81959,C81959,,Laboratory Tests;Chemistry Tests;Hematology Tests;Coagulation Study;Blood Protein Measurements,Factor III;FACTIII;Soluble CD142;Tissue Factor CD142,,The determination of the amount of factor III present in a sample.,,,,,,,,
2025-12-16,Heart Rate,C49677,C49677,C49672,Vital Signs,HR,Quantitative,"The number of heartbeats per unit of time, usually expressed as beats per minute.",http://loinc.org/,LOINC,8867-4,C73688,C73688,Count per Minute,string,Beats per Minute
2025-12-16,Heart Rate,C49677,C49677,C49672,Vital Signs,HR,Quantitative,"The number of heartbeats per unit of time, usually expressed as beats per minute.",http://loinc.org/,LOINC,8867-4,C82535,C82535,Test Method,string,Acoustic Monitoring;Auscaltation Manual;Palpation;Oscillometry;Pulse Oximetry;EKG/ECG
2025-12-16,Heart Rate,C49677,C49677,C49672,Vital Signs,HR,Quantitative,"The number of heartbeats per unit of time, usually expressed as beats per minute.",http://loinc.org/,LOINC,8867-4,C70856,C70856,Observation Result,integer,
2025-12-16,Heart Rate,C49677,C49677,C49672,Vital Signs,HR,Quantitative,"The number of heartbeats per unit of time, usually expressed as beats per minute.",http://loinc.org/,LOINC,8867-4,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Heart Rate,C49677,C49677,C49672,Vital Signs,HR,Quantitative,"The number of heartbeats per unit of time, usually expressed as beats per minute.",http://loinc.org/,LOINC,8867-4,C25185,C25185,Laterality,string,Left;Right
2025-12-16,Heart Rate,C49677,C49677,C49672,Vital Signs,HR,Quantitative,"The number of heartbeats per unit of time, usually expressed as beats per minute.",http://loinc.org/,LOINC,8867-4,C13717,C13717,Anatomic Site,string,Wrist;Neck;Temple;Groin;Behind the knees;On top of the foot
2025-12-16,Heart Rate,C49677,C49677,C49672,Vital Signs,HR,Quantitative,"The number of heartbeats per unit of time, usually expressed as beats per minute.",http://loinc.org/,LOINC,8867-4,C62164,C62164,Body Position,string,Decubitus;Fowlers;Lateral Decubitus;Left Lateral Decubitus;Prone;Reverse Trendelenburg;Right Lateral Decubitus;Semi-Fowlers;Semi-Recumbent;Sitting;Sitting;Legs Dependent;Sling;Standing;Standing;Bent Forward;Supine;Trendelenburg;Unconstrained
2025-12-16,Indirect Antiglobulin Test,C91372,C91372,C25163,Laboratory Tests;Hematology Tests;Immunohematology Tests;Autoantibody Measurements;Antibody Measurements;Immunology Tests;Coombs Tests,ANGLBIND;Indirect Coombs Test;Indirect Anti-human Globulin Test;Antiglobulin Test Indirect,Ordinal;Quantitative,A test that uses Coombs' reagent to detect the presence of anti-erythrocyte antibodies in serum.,,,,C70856,C70856,Observation Result,string,Positive;Negative;1:8;1:64
2025-12-16,Indirect Antiglobulin Test,C91372,C91372,C25163,Laboratory Tests;Hematology Tests;Immunohematology Tests;Autoantibody Measurements;Antibody Measurements;Immunology Tests;Coombs Tests,ANGLBIND;Indirect Coombs Test;Indirect Anti-human Globulin Test;Antiglobulin Test Indirect,Ordinal;Quantitative,A test that uses Coombs' reagent to detect the presence of anti-erythrocyte antibodies in serum.,,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Indirect Antiglobulin Test,C91372,C91372,C25163,Laboratory Tests;Hematology Tests;Immunohematology Tests;Autoantibody Measurements;Antibody Measurements;Immunology Tests;Coombs Tests,ANGLBIND;Indirect Coombs Test;Indirect Anti-human Globulin Test;Antiglobulin Test Indirect,Ordinal;Quantitative,A test that uses Coombs' reagent to detect the presence of anti-erythrocyte antibodies in serum.,,,,C93566,C93566,Fasting Status Indicator,boolean,
2025-12-16,Indirect Antiglobulin Test,C91372,C91372,C25163,Laboratory Tests;Hematology Tests;Immunohematology Tests;Autoantibody Measurements;Antibody Measurements;Immunology Tests;Coombs Tests,ANGLBIND;Indirect Coombs Test;Indirect Anti-human Globulin Test;Antiglobulin Test Indirect,Ordinal;Quantitative,A test that uses Coombs' reagent to detect the presence of anti-erythrocyte antibodies in serum.,,,,C70713,C70713,Biospecimen Type,string,Serum;Plasma
2025-12-16,International Normalized Ratio of Prothrombin Time,C64805,C64805,C62656,Laboratory Tests;Chemistry Tests;Hematology Tests;Protein or Enzyme Type Measurements;Prothrombin Measurements;Coagulation Study,INR;Prothrombin Intl. Normalized Ratio,Quantitative,A measure of the extrinsic pathway of coagulation. The International Normalized Ratio of Prothrombin Time (INR) is the ratio of a patient prothrombin time to a normal (control) sample raised to the power of the International Sensitivity Index (ISI) with a range of 0.8 to 1.2 seconds.,,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,International Normalized Ratio of Prothrombin Time,C64805,C64805,C62656,Laboratory Tests;Chemistry Tests;Hematology Tests;Protein or Enzyme Type Measurements;Prothrombin Measurements;Coagulation Study,INR;Prothrombin Intl. Normalized Ratio,Quantitative,A measure of the extrinsic pathway of coagulation. The International Normalized Ratio of Prothrombin Time (INR) is the ratio of a patient prothrombin time to a normal (control) sample raised to the power of the International Sensitivity Index (ISI) with a range of 0.8 to 1.2 seconds.,,,,C42574,C42574,Unit of Time,string,Seconds
2025-12-16,International Normalized Ratio of Prothrombin Time,C64805,C64805,C62656,Laboratory Tests;Chemistry Tests;Hematology Tests;Protein or Enzyme Type Measurements;Prothrombin Measurements;Coagulation Study,INR;Prothrombin Intl. Normalized Ratio,Quantitative,A measure of the extrinsic pathway of coagulation. The International Normalized Ratio of Prothrombin Time (INR) is the ratio of a patient prothrombin time to a normal (control) sample raised to the power of the International Sensitivity Index (ISI) with a range of 0.8 to 1.2 seconds.,,,,C70713,C70713,Biospecimen Type,string,Blood;Platelet Poor Plasma;Capillary Blood
2025-12-16,International Normalized Ratio of Prothrombin Time,C64805,C64805,C62656,Laboratory Tests;Chemistry Tests;Hematology Tests;Protein or Enzyme Type Measurements;Prothrombin Measurements;Coagulation Study,INR;Prothrombin Intl. Normalized Ratio,Quantitative,A measure of the extrinsic pathway of coagulation. The International Normalized Ratio of Prothrombin Time (INR) is the ratio of a patient prothrombin time to a normal (control) sample raised to the power of the International Sensitivity Index (ISI) with a range of 0.8 to 1.2 seconds.,,,,C93566,C93566,Fasting Status Indicator,boolean,
2025-12-16,International Normalized Ratio of Prothrombin Time,C64805,C64805,C62656,Laboratory Tests;Chemistry Tests;Hematology Tests;Protein or Enzyme Type Measurements;Prothrombin Measurements;Coagulation Study,INR;Prothrombin Intl. Normalized Ratio,Quantitative,A measure of the extrinsic pathway of coagulation. The International Normalized Ratio of Prothrombin Time (INR) is the ratio of a patient prothrombin time to a normal (control) sample raised to the power of the International Sensitivity Index (ISI) with a range of 0.8 to 1.2 seconds.,,,,C70856,C70856,Observation Result,integer,
2025-12-16,Leukocyte Count,C51948,C51948,C28133,Laboratory Tests;Hematology Tests;Blood Cell Counts,WBC;White Blood Cells,Quantitative;Ordinal,A test to determine the number of leukocytes in a biospecimen.,,,,C93566,C93566,Fasting Status Indicator,boolean,
2025-12-16,Leukocyte Count,C51948,C51948,C28133,Laboratory Tests;Hematology Tests;Blood Cell Counts,WBC;White Blood Cells,Quantitative;Ordinal,A test to determine the number of leukocytes in a biospecimen.,,,,C82535,C82535,Test Method,string,
2025-12-16,Leukocyte Count,C51948,C51948,C28133,Laboratory Tests;Hematology Tests;Blood Cell Counts,WBC;White Blood Cells,Quantitative;Ordinal,A test to determine the number of leukocytes in a biospecimen.,,,,C70856,C70856,Observation Result,decimal,
2025-12-16,Leukocyte Count,C51948,C51948,C28133,Laboratory Tests;Hematology Tests;Blood Cell Counts,WBC;White Blood Cells,Quantitative;Ordinal,A test to determine the number of leukocytes in a biospecimen.,,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Leukocyte Count,C51948,C51948,C28133,Laboratory Tests;Hematology Tests;Blood Cell Counts,WBC;White Blood Cells,Quantitative;Ordinal,A test to determine the number of leukocytes in a biospecimen.,,,,C70713,C70713,Biospecimen Type,string,Blood;Urine;Stool
2025-12-16,Leukocyte Count,C51948,C51948,C28133,Laboratory Tests;Hematology Tests;Blood Cell Counts,WBC;White Blood Cells,Quantitative;Ordinal,A test to determine the number of leukocytes in a biospecimen.,,,,C67391,C67391,Unit of Number Concentration,string,
2025-12-16,MVAI - Dominant Feature,C191064,C191064,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Dominant Feature;MVAI105;MVAI - Dominant Feature,Ordinal,Modified Van Assche Index (MVAI) Dominant feature.,,,,C25372,C25372,Category,string,MVAI
2025-12-16,MVAI - Dominant Feature,C191064,C191064,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Dominant Feature;MVAI105;MVAI - Dominant Feature,Ordinal,Modified Van Assche Index (MVAI) Dominant feature.,,,,C91106,C91106,Clinical or Research Assessment Answer,string,Fibrous;Granulation tissue;Fluid/pus
2025-12-16,MVAI - Dominant Feature,C191064,C191064,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Dominant Feature;MVAI105;MVAI - Dominant Feature,Ordinal,Modified Van Assche Index (MVAI) Dominant feature.,,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,MVAI - Dominant Feature,C191064,C191064,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Dominant Feature;MVAI105;MVAI - Dominant Feature,Ordinal,Modified Van Assche Index (MVAI) Dominant feature.,,,,C46126,C46126,Ordinal Position,integer,0;1;2
2025-12-16,MVAI - Extension,C191060,C191060,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Extension;MVAI101;MVAI - Extension,Ordinal,Modified Van Assche Index (MVAI) Extension.,,,,C25372,C25372,Category,string,MVAI
2025-12-16,MVAI - Extension,C191060,C191060,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Extension;MVAI101;MVAI - Extension,Ordinal,Modified Van Assche Index (MVAI) Extension.,,,,C46126,C46126,Ordinal Position,integer,0;1;2;3
2025-12-16,MVAI - Extension,C191060,C191060,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Extension;MVAI101;MVAI - Extension,Ordinal,Modified Van Assche Index (MVAI) Extension.,,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,MVAI - Extension,C191060,C191060,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Extension;MVAI101;MVAI - Extension,Ordinal,Modified Van Assche Index (MVAI) Extension.,,,,C91106,C91106,Clinical or Research Assessment Answer,string,Absent;Infralevatoric;Horseshoe configuration;Supralevatoric
2025-12-16,MVAI - Hyperintensity T2-weighted Images,C191061,C191061,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Hyperintensity T2-weighted Images;MVAI102;MVAI - Hyperintensity T2-weighted Images,Ordinal,Modified Van Assche Index (MVAI) Hyperintensity T2-weighted images.,,,,C46126,C46126,Ordinal Position,integer,0;1;2
2025-12-16,MVAI - Hyperintensity T2-weighted Images,C191061,C191061,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Hyperintensity T2-weighted Images;MVAI102;MVAI - Hyperintensity T2-weighted Images,Ordinal,Modified Van Assche Index (MVAI) Hyperintensity T2-weighted images.,,,,C91106,C91106,Clinical or Research Assessment Answer,string,Absent;Mild;Pronounced
2025-12-16,MVAI - Hyperintensity T2-weighted Images,C191061,C191061,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Hyperintensity T2-weighted Images;MVAI102;MVAI - Hyperintensity T2-weighted Images,Ordinal,Modified Van Assche Index (MVAI) Hyperintensity T2-weighted images.,,,,C25372,C25372,Category,string,MVAI
2025-12-16,MVAI - Hyperintensity T2-weighted Images,C191061,C191061,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Hyperintensity T2-weighted Images;MVAI102;MVAI - Hyperintensity T2-weighted Images,Ordinal,Modified Van Assche Index (MVAI) Hyperintensity T2-weighted images.,,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,MVAI - Inflammatory Mass,C191063,C191063,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Inflammatory Mass;MVAI104;MVAI - Inflammatory Mass,Ordinal,Modified Van Assche Index (MVAI) Inflammatory mass.,,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,MVAI - Inflammatory Mass,C191063,C191063,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Inflammatory Mass;MVAI104;MVAI - Inflammatory Mass,Ordinal,Modified Van Assche Index (MVAI) Inflammatory mass.,,,,C46126,C46126,Ordinal Position,integer,0;1;2;3;4;5
2025-12-16,MVAI - Inflammatory Mass,C191063,C191063,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Inflammatory Mass;MVAI104;MVAI - Inflammatory Mass,Ordinal,Modified Van Assche Index (MVAI) Inflammatory mass.,,,,C25372,C25372,Category,string,MVAI
2025-12-16,MVAI - Inflammatory Mass,C191063,C191063,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Inflammatory Mass;MVAI104;MVAI - Inflammatory Mass,Ordinal,Modified Van Assche Index (MVAI) Inflammatory mass.,,,,C91106,C91106,Clinical or Research Assessment Answer,string,Absent;Diffuse;Focal;Collection - small;Collection - medium;Collection - large
2025-12-16,MVAI - Rectal Wall Involvement,C191062,C191062,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Rectal Wall Involvement;MVAI103;MVAI - Rectal Wall Involvement,Ordinal,Modified Van Assche Index (MVAI) Rectal wall involvement.,,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,MVAI - Rectal Wall Involvement,C191062,C191062,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Rectal Wall Involvement;MVAI103;MVAI - Rectal Wall Involvement,Ordinal,Modified Van Assche Index (MVAI) Rectal wall involvement.,,,,C46126,C46126,Ordinal Position,integer,0;1;2
2025-12-16,MVAI - Rectal Wall Involvement,C191062,C191062,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Rectal Wall Involvement;MVAI103;MVAI - Rectal Wall Involvement,Ordinal,Modified Van Assche Index (MVAI) Rectal wall involvement.,,,,C91106,C91106,Clinical or Research Assessment Answer,string,Normal;Thickened;Increased signal intensity
2025-12-16,MVAI - Rectal Wall Involvement,C191062,C191062,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Rectal Wall Involvement;MVAI103;MVAI - Rectal Wall Involvement,Ordinal,Modified Van Assche Index (MVAI) Rectal wall involvement.,,,,C25372,C25372,Category,string,MVAI
2025-12-16,MVAI - Total Score,C191065,C191065,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Total Score;MVAI106;MVAI - Total Score,Ordinal,Modified Van Assche Index (MVAI) Total score.,,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,MVAI - Total Score,C191065,C191065,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Total Score;MVAI106;MVAI - Total Score,Ordinal,Modified Van Assche Index (MVAI) Total score.,,,,C25372,C25372,Category,string,MVAI
2025-12-16,MVAI - Total Score,C191065,C191065,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Total Score;MVAI106;MVAI - Total Score,Ordinal,Modified Van Assche Index (MVAI) Total score.,,,,C91106,C91106,Clinical or Research Assessment Answer,string,
2025-12-16,MVAI - Total Score,C191065,C191065,C190945,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI1-Total Score;MVAI106;MVAI - Total Score,Ordinal,Modified Van Assche Index (MVAI) Total score.,,,,C46126,C46126,Ordinal Position,integer,
2025-12-16,Mature Plasma Cell to Total Cell Ratio Measurement,C98869,C98869,C67208,Laboratory Tests;Hematology Tests;Blood Cell Counts,PLSMCECE;Mature Plasma Cells/Total Cells,Quantitative,The determination of the ratio of mature plasma cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.,,,,C48570,C48570,Percent Unit,string,
2025-12-16,Mature Plasma Cell to Total Cell Ratio Measurement,C98869,C98869,C67208,Laboratory Tests;Hematology Tests;Blood Cell Counts,PLSMCECE;Mature Plasma Cells/Total Cells,Quantitative,The determination of the ratio of mature plasma cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.,,,,C93566,C93566,Fasting Status Indicator,boolean,
2025-12-16,Mature Plasma Cell to Total Cell Ratio Measurement,C98869,C98869,C67208,Laboratory Tests;Hematology Tests;Blood Cell Counts,PLSMCECE;Mature Plasma Cells/Total Cells,Quantitative,The determination of the ratio of mature plasma cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.,,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Mature Plasma Cell to Total Cell Ratio Measurement,C98869,C98869,C67208,Laboratory Tests;Hematology Tests;Blood Cell Counts,PLSMCECE;Mature Plasma Cells/Total Cells,Quantitative,The determination of the ratio of mature plasma cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.,,,,C70856,C70856,Observation Result,string,
2025-12-16,Mature Plasma Cell to Total Cell Ratio Measurement,C98869,C98869,C67208,Laboratory Tests;Hematology Tests;Blood Cell Counts,PLSMCECE;Mature Plasma Cells/Total Cells,Quantitative,The determination of the ratio of mature plasma cells compared to total cells present in a sample. The measurement may be expressed as a ratio or percentage.,,,,C70713,C70713,Biospecimen Type,string,
2025-12-16,Medical History Reported Term [RETIRED],C83118,C83118,C82571,Reported Events;Medical History Events;Medical Conditions;Presenting Conditions,Medical History;MHTERM,Nominal,The verbatim description of the medical history being reported. [RETIRED],,,,C87897,C87897,Medical History Pre-specified,boolean,Y;N
2025-12-16,Medical History Reported Term [RETIRED],C83118,C83118,C82571,Reported Events;Medical History Events;Medical Conditions;Presenting Conditions,Medical History;MHTERM,Nominal,The verbatim description of the medical history being reported. [RETIRED],,,,C83118,C83118,Medical History Reported Term,string,
2025-12-16,Medical History Reported Term [RETIRED],C83118,C83118,C82571,Reported Events;Medical History Events;Medical Conditions;Presenting Conditions,Medical History;MHTERM,Nominal,The verbatim description of the medical history being reported. [RETIRED],,,,C83018,C83018,Medical History Category,string,
2025-12-16,Medical History Reported Term [RETIRED],C83118,C83118,C82571,Reported Events;Medical History Events;Medical Conditions;Presenting Conditions,Medical History;MHTERM,Nominal,The verbatim description of the medical history being reported. [RETIRED],,,,C83143,C83143,Medical History Subcategory,string,
2025-12-16,Medical History Reported Term [RETIRED],C83118,C83118,C82571,Reported Events;Medical History Events;Medical Conditions;Presenting Conditions,Medical History;MHTERM,Nominal,The verbatim description of the medical history being reported. [RETIRED],,,,C83067,C83067,Medical History Occurrence,boolean,Y;N
2025-12-16,Medical History Reported Term [RETIRED],C83118,C83118,C82571,Reported Events;Medical History Events;Medical Conditions;Presenting Conditions,Medical History;MHTERM,Nominal,The verbatim description of the medical history being reported. [RETIRED],,,,C83346,C83346,Medical History Dictionary Derived Term,string,
2025-12-16,Microbial-induced IgG Antibody Measurement,C181394,C181394,C187780,Laboratory Tests;Immunogenicity Specimen Assessments;Immunoglobulin G Measurements;Microbial-induced Antibody Measurement,MBIGGAB;Microbial-induced IgG Antibody,Quantitative;Ordinal,"The determination of the microbial-induced, binding IgG antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe.",,,,C218437,C218437,Immunogenicity Specimen Test Operational Objective,string,Screen;Confirm;Quantify;Overall Subject Status
2025-12-16,Microbial-induced IgG Antibody Measurement,C181394,C181394,C187780,Laboratory Tests;Immunogenicity Specimen Assessments;Immunoglobulin G Measurements;Microbial-induced Antibody Measurement,MBIGGAB;Microbial-induced IgG Antibody,Quantitative;Ordinal,"The determination of the microbial-induced, binding IgG antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe.",,,,C25372,C25372,Category,string,
2025-12-16,Microbial-induced IgG Antibody Measurement,C181394,C181394,C187780,Laboratory Tests;Immunogenicity Specimen Assessments;Immunoglobulin G Measurements;Microbial-induced Antibody Measurement,MBIGGAB;Microbial-induced IgG Antibody,Quantitative;Ordinal,"The determination of the microbial-induced, binding IgG antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe.",,,,C117062,C117062,"Measurement, Test or Examination Detail",string,Radioallergosorbent test
2025-12-16,Microbial-induced IgG Antibody Measurement,C181394,C181394,C187780,Laboratory Tests;Immunogenicity Specimen Assessments;Immunoglobulin G Measurements;Microbial-induced Antibody Measurement,MBIGGAB;Microbial-induced IgG Antibody,Quantitative;Ordinal,"The determination of the microbial-induced, binding IgG antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe.",,,,C46126,C46126,Ordinal Position,integer,0;1;2;3;4;5;6
2025-12-16,Microbial-induced IgG Antibody Measurement,C181394,C181394,C187780,Laboratory Tests;Immunogenicity Specimen Assessments;Immunoglobulin G Measurements;Microbial-induced Antibody Measurement,MBIGGAB;Microbial-induced IgG Antibody,Quantitative;Ordinal,"The determination of the microbial-induced, binding IgG antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe.",,,,C70856,C70856,Observation Result,string,0 Absent or undetectable allergen specific IgG;1 Low level of allergen specific IgG;2 Moderate level of allergen specific IgG;3 High level of allergen specific IgG;4 Very high level of allergen specific IgG;5 Ultra high level of allergen specific IgG;6 Extremely high level of allergen specific IgG
2025-12-16,Microbial-induced IgG Antibody Measurement,C181394,C181394,C187780,Laboratory Tests;Immunogenicity Specimen Assessments;Immunoglobulin G Measurements;Microbial-induced Antibody Measurement,MBIGGAB;Microbial-induced IgG Antibody,Quantitative;Ordinal,"The determination of the microbial-induced, binding IgG antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe.",,,,C48207,C48207,Unit of Concentration,string,IU/mL;ng/mL;ng/dL;U/mL
2025-12-16,Microbial-induced IgG Antibody Measurement,C181394,C181394,C187780,Laboratory Tests;Immunogenicity Specimen Assessments;Immunoglobulin G Measurements;Microbial-induced Antibody Measurement,MBIGGAB;Microbial-induced IgG Antibody,Quantitative;Ordinal,"The determination of the microbial-induced, binding IgG antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe.",,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Microbial-induced IgG Antibody Measurement,C181394,C181394,C187780,Laboratory Tests;Immunogenicity Specimen Assessments;Immunoglobulin G Measurements;Microbial-induced Antibody Measurement,MBIGGAB;Microbial-induced IgG Antibody,Quantitative;Ordinal,"The determination of the microbial-induced, binding IgG antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe.",,,,C25692,C25692,Subcategory,string,
2025-12-16,Microbial-induced IgG Antibody Measurement,C181394,C181394,C187780,Laboratory Tests;Immunogenicity Specimen Assessments;Immunoglobulin G Measurements;Microbial-induced Antibody Measurement,MBIGGAB;Microbial-induced IgG Antibody,Quantitative;Ordinal,"The determination of the microbial-induced, binding IgG antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe.",,,,C42647,C42647,Binder Excipient,string,Adenoviridae;Alternaria Alternata;Aspergillus Fumigatus;Borrelia Burgdorferi;Chlamydia Trachomatis;Chlamydophila Pneumoniae;Clostridium Tetani;Coccidioides;Corynebacterium Diphtheriae;Cytomegalovirus;Dengue Virus;Helicobacter Pylori;Hepatitis A Virus;Hepatitis D Virus;Hepatitis E Virus;Human Herpesvirus 1;Human Herpesvirus 2;Human Parvovirus B19;Influenza A Virus;Influenza B Virus;Legionella Pneumophila;Measles Morbillivirus;Mumps Rubulavirus;Mycobacterium Tuberculosis;Mycoplasma Pneumoniae;Norovirus Genogroup Ii.4;Penicillium Chrysogenum;Rubella Virus;Severe Acute Respiratory Syndrome Coronavirus 2;Streptococcus Pneumoniae;Streptococcus Pneumoniae Danish Serotype 1;Streptococcus Pneumoniae Danish Serotype 10A;Streptococcus Pneumoniae Danish Serotype 11A;Streptococcus Pneumoniae Danish Serotype 12F;Streptococcus Pneumoniae Danish Serotype 14;Streptococcus Pneumoniae Danish Serotype 15B;Streptococcus Pneumoniae Danish Serotype 17F;Streptococcus Pneumoniae Danish Serotype 18C;Streptococcus Pneumoniae Danish Serotype 19A;Streptococcus Pneumoniae Danish Serotype 19F;Streptococcus Pneumoniae Danish Serotype 2;Streptococcus Pneumoniae Danish Serotype 20A;Streptococcus Pneumoniae Danish Serotype 22F;Streptococcus Pneumoniae Danish Serotype 23F;Streptococcus Pneumoniae Danish Serotype 3;Streptococcus Pneumoniae Danish Serotype 33F;Streptococcus Pneumoniae Danish Serotype 4;Streptococcus Pneumoniae Danish Serotype 5;Streptococcus Pneumoniae Danish Serotype 6B;Streptococcus Pneumoniae Danish Serotype 7F;Streptococcus Pneumoniae Danish Serotype 8;Streptococcus Pneumoniae Danish Serotype 9N;Streptococcus Pneumoniae Danish Serotype 9V;Strongyloides;Toxoplasma Gondii;Varicella Zoster Virus;Vibrio Cholera Toxin B Subunit;Clostridium Tetani Toxoid;Epstein-Barr Virus Capsid Antigen;Hepatitis B Virus Core Antigen;Herpes Simplex Viruses;Epstein-Barr Virus Early D Antigen;Epstein-Barr Virus Nuclear Antigen 1
2025-12-16,Microbial-induced IgG Antibody Measurement,C181394,C181394,C187780,Laboratory Tests;Immunogenicity Specimen Assessments;Immunoglobulin G Measurements;Microbial-induced Antibody Measurement,MBIGGAB;Microbial-induced IgG Antibody,Quantitative;Ordinal,"The determination of the microbial-induced, binding IgG antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe.",,,,C82535,C82535,Test Method,string,Immunoassay;Enzyme-linked Immunosorbent Assay
2025-12-16,Microbial-induced IgG Antibody Measurement,C181394,C181394,C187780,Laboratory Tests;Immunogenicity Specimen Assessments;Immunoglobulin G Measurements;Microbial-induced Antibody Measurement,MBIGGAB;Microbial-induced IgG Antibody,Quantitative;Ordinal,"The determination of the microbial-induced, binding IgG antibody in a biological specimen; the production of this antibody may be triggered by naturally occurring infection and/or vaccination using a whole microbe or component(s) of a microbe.",,,,C70713,C70713,Biospecimen Type,string,Serum;Plasma
2025-12-16,Modified Van Assche Index Clinical Classification,C191038,C191038,,Clinical or Research Assessment Classification;Modified Van Assche Index Clinical Classification Question;Modified Van Assche Index Clinical Classification;MVAI;MVAI1,MVAI;MVAI1,,A standardized scoring system originally developed in 2003 and modified in 2017 that utilizes quantitative radiological evaluation to assess the severity and disease response in perianal fistulizing Crohn disease.,,,,,,,,
2025-12-16,Modified Van Assche Index Clinical Classification Question,C190945,C190945,C211913,QRS Instrument Questions,,,A question associated with the Modified Van Assche Index clinical classification.,,,,,,,,
2025-12-16,Partial Pressure of Oxygen Measurement,C71251,C71251,C71252,Laboratory Tests;Chemistry Tests;Arterial Blood Gas Measurements,PaO2;Partial Pressure O2;PO2,Quantitative,Measures the pressure of oxygen dissolved in the blood and how well oxygen is able to move from the airspace of the lungs into the blood.,,,,C70856,C70856,Observation Result,decimal,
2025-12-16,Partial Pressure of Oxygen Measurement,C71251,C71251,C71252,Laboratory Tests;Chemistry Tests;Arterial Blood Gas Measurements,PaO2;Partial Pressure O2;PO2,Quantitative,Measures the pressure of oxygen dissolved in the blood and how well oxygen is able to move from the airspace of the lungs into the blood.,,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Partial Pressure of Oxygen Measurement,C71251,C71251,C71252,Laboratory Tests;Chemistry Tests;Arterial Blood Gas Measurements,PaO2;Partial Pressure O2;PO2,Quantitative,Measures the pressure of oxygen dissolved in the blood and how well oxygen is able to move from the airspace of the lungs into the blood.,,,,C70713,C70713,Biospecimen Type,string,Blood;Arterial Blood;Venous Blood;Arterial Cord Blood;Venous Cord Blood
2025-12-16,Partial Pressure of Oxygen Measurement,C71251,C71251,C71252,Laboratory Tests;Chemistry Tests;Arterial Blood Gas Measurements,PaO2;Partial Pressure O2;PO2,Quantitative,Measures the pressure of oxygen dissolved in the blood and how well oxygen is able to move from the airspace of the lungs into the blood.,,,,C49669,C49669,Unit of Pressure,string,mmHg
2025-12-16,Prothrombin Activity Measurement,C98774,C98774,,Laboratory Tests;Chemistry Tests;Protein or Enzyme Type Measurements;Prothrombin Measurements;Coagulation Study,Factor II Activity;Prothrombin Activity,,The determination of the biological activity of prothrombin in a sample.,,,,,,,,
2025-12-16,Prothrombin Time,C62656,C62656,C98774,Laboratory Tests;Chemistry Tests;Coagulation Study;Prothrombin Activity Measurements;Drug-Induced Liver Injury;DILI,PT,Quantitative,"A measurement of the clotting time of plasma recalcified in the presence of excess tissue thromboplastin; it is a measure of the extrinsic pathway of coagulation. It is used to determine the clotting tendency of blood, in the measure of warfarin dosage, liver damage and vitamin K status. Factors measured are fibrinogen, prothrombin, and factors V, VII, and X.",,,,C70713,C70713,Biospecimen Type,string,Blood;Platelet Poor Plasma
2025-12-16,Prothrombin Time,C62656,C62656,C98774,Laboratory Tests;Chemistry Tests;Coagulation Study;Prothrombin Activity Measurements;Drug-Induced Liver Injury;DILI,PT,Quantitative,"A measurement of the clotting time of plasma recalcified in the presence of excess tissue thromboplastin; it is a measure of the extrinsic pathway of coagulation. It is used to determine the clotting tendency of blood, in the measure of warfarin dosage, liver damage and vitamin K status. Factors measured are fibrinogen, prothrombin, and factors V, VII, and X.",,,,C70856,C70856,Observation Result,decimal,
2025-12-16,Prothrombin Time,C62656,C62656,C98774,Laboratory Tests;Chemistry Tests;Coagulation Study;Prothrombin Activity Measurements;Drug-Induced Liver Injury;DILI,PT,Quantitative,"A measurement of the clotting time of plasma recalcified in the presence of excess tissue thromboplastin; it is a measure of the extrinsic pathway of coagulation. It is used to determine the clotting tendency of blood, in the measure of warfarin dosage, liver damage and vitamin K status. Factors measured are fibrinogen, prothrombin, and factors V, VII, and X.",,,,C93566,C93566,Fasting Status Indicator,boolean,
2025-12-16,Prothrombin Time,C62656,C62656,C98774,Laboratory Tests;Chemistry Tests;Coagulation Study;Prothrombin Activity Measurements;Drug-Induced Liver Injury;DILI,PT,Quantitative,"A measurement of the clotting time of plasma recalcified in the presence of excess tissue thromboplastin; it is a measure of the extrinsic pathway of coagulation. It is used to determine the clotting tendency of blood, in the measure of warfarin dosage, liver damage and vitamin K status. Factors measured are fibrinogen, prothrombin, and factors V, VII, and X.",,,,C42574,C42574,Unit of Time,string,Seconds
2025-12-16,Prothrombin Time,C62656,C62656,C98774,Laboratory Tests;Chemistry Tests;Coagulation Study;Prothrombin Activity Measurements;Drug-Induced Liver Injury;DILI,PT,Quantitative,"A measurement of the clotting time of plasma recalcified in the presence of excess tissue thromboplastin; it is a measure of the extrinsic pathway of coagulation. It is used to determine the clotting tendency of blood, in the measure of warfarin dosage, liver damage and vitamin K status. Factors measured are fibrinogen, prothrombin, and factors V, VII, and X.",,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Pulse Rate,C49676,C49676,C49672,Vital Signs,Pulse,Quantitative,"The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomic sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot.",,,,C73688,C73688,Count per Minute,string,Beats per Minute
2025-12-16,Pulse Rate,C49676,C49676,C49672,Vital Signs,Pulse,Quantitative,"The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomic sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot.",,,,C13717,C13717,Anatomic Site,string,Wrist;Neck;Temple;Groin;Behind the knees;On top of the foot
2025-12-16,Pulse Rate,C49676,C49676,C49672,Vital Signs,Pulse,Quantitative,"The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomic sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot.",,,,C70856,C70856,Observation Result,integer,
2025-12-16,Pulse Rate,C49676,C49676,C49672,Vital Signs,Pulse,Quantitative,"The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomic sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot.",,,,C82535,C82535,Test Method,string,Acoustic Monitoring;Auscaltation Manual;Palpation;Oscillometry;Pulse Oximetry;EKG/ECG
2025-12-16,Pulse Rate,C49676,C49676,C49672,Vital Signs,Pulse,Quantitative,"The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomic sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot.",,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Pulse Rate,C49676,C49676,C49672,Vital Signs,Pulse,Quantitative,"The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomic sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot.",,,,C62164,C62164,Body Position,string,Decubitus;Fowlers;Lateral Decubitus;Left Lateral Decubitus;Prone;Reverse Trendelenburg;Right Lateral Decubitus;Semi-Fowlers;Semi-Recumbent;Sitting;Sitting;Legs Dependent;Sling;Standing;Standing;Bent Forward;Supine;Trendelenburg;Unconstrained
2025-12-16,Pulse Rate,C49676,C49676,C49672,Vital Signs,Pulse,Quantitative,"The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomic sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot.",,,,C25185,C25185,Laterality,string,Left;Right
2025-12-16,Reported Event Term [RETIRED],C82571,C82571,,Reported Events;Medical History Events;Medical Conditions;Presenting Conditions,,,The collected name for an event observation. [RETIRED],,,,,,,,
2025-12-16,SARS-CoV-2 RNA Measurement,C171531,C171531,C171532,Laboratory Tests;Microbiology Tests;Virology Tests;COVID-19 Tests;SARS-CoV-2 Tests,SAR2RNA;SARS-CoV-2 RNA,Quantitative,The determination of the amount of SARS-CoV-2 RNA in a sample.,,,,C171435,C171435,Specimen Anatomic Site,string,Nasopharynx;Throat;Alveolus
2025-12-16,SARS-CoV-2 RNA Measurement,C171531,C171531,C171532,Laboratory Tests;Microbiology Tests;Virology Tests;COVID-19 Tests;SARS-CoV-2 Tests,SAR2RNA;SARS-CoV-2 RNA,Quantitative,The determination of the amount of SARS-CoV-2 RNA in a sample.,,,,C70713,C70713,Biospecimen Type,string,Endotrachial Fluid;Swabbed Material;Lavage Fluid;Blood;Serum;Sputum
2025-12-16,SARS-CoV-2 RNA Measurement,C171531,C171531,C171532,Laboratory Tests;Microbiology Tests;Virology Tests;COVID-19 Tests;SARS-CoV-2 Tests,SAR2RNA;SARS-CoV-2 RNA,Quantitative,The determination of the amount of SARS-CoV-2 RNA in a sample.,,,,C70700,C70700,Biospecimen Collection Method,string,Swab;Lavage
2025-12-16,SARS-CoV-2 RNA Measurement,C171531,C171531,C171532,Laboratory Tests;Microbiology Tests;Virology Tests;COVID-19 Tests;SARS-CoV-2 Tests,SAR2RNA;SARS-CoV-2 RNA,Quantitative,The determination of the amount of SARS-CoV-2 RNA in a sample.,,,,C82535,C82535,Test Method,string,Quantitative Reverse Transcriptase Polymerase Chain Reaction
2025-12-16,SARS-CoV-2 RNA Measurement,C171531,C171531,C171532,Laboratory Tests;Microbiology Tests;Virology Tests;COVID-19 Tests;SARS-CoV-2 Tests,SAR2RNA;SARS-CoV-2 RNA,Quantitative,The determination of the amount of SARS-CoV-2 RNA in a sample.,,,,C117062,C117062,"Measurement, Test or Examination Detail",string,Viral Load;Quantification Cycle Number
2025-12-16,SARS-CoV-2 RNA Measurement,C171531,C171531,C171532,Laboratory Tests;Microbiology Tests;Virology Tests;COVID-19 Tests;SARS-CoV-2 Tests,SAR2RNA;SARS-CoV-2 RNA,Quantitative,The determination of the amount of SARS-CoV-2 RNA in a sample.,,,,C70856,C70856,Observation Result,string,
2025-12-16,SARS-CoV-2 RNA Measurement,C171531,C171531,C171532,Laboratory Tests;Microbiology Tests;Virology Tests;COVID-19 Tests;SARS-CoV-2 Tests,SAR2RNA;SARS-CoV-2 RNA,Quantitative,The determination of the amount of SARS-CoV-2 RNA in a sample.,,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,SARS-CoV-2 RNA Measurement,C171531,C171531,C171532,Laboratory Tests;Microbiology Tests;Virology Tests;COVID-19 Tests;SARS-CoV-2 Tests,SAR2RNA;SARS-CoV-2 RNA,Quantitative,The determination of the amount of SARS-CoV-2 RNA in a sample.,,,,C67391,C67391,Unit of Number Concentration,string,log 10 copies/ml
2025-12-16,Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Measurement,C171439,C171439,C171532,Laboratory Tests;Microbiology Tests;Virology Tests;COVID-19 Tests;SARS-CoV-2 Tests,SARS-CoV-2 Antibody Detection;SARS-CoV-2 Antibody Test;COVID-19 Antibody Test;COVID-19 Antibody Detection;SAR2AB,Quantitative;Ordinal,The determination of the amount of severe acute respiratory syndrome coronavirus 2 antibody in a sample.,,,,C70713,C70713,Biospecimen Type,string,Serum;Plasma
2025-12-16,Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Measurement,C171439,C171439,C171532,Laboratory Tests;Microbiology Tests;Virology Tests;COVID-19 Tests;SARS-CoV-2 Tests,SARS-CoV-2 Antibody Detection;SARS-CoV-2 Antibody Test;COVID-19 Antibody Test;COVID-19 Antibody Detection;SAR2AB,Quantitative;Ordinal,The determination of the amount of severe acute respiratory syndrome coronavirus 2 antibody in a sample.,,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Measurement,C171439,C171439,C171532,Laboratory Tests;Microbiology Tests;Virology Tests;COVID-19 Tests;SARS-CoV-2 Tests,SARS-CoV-2 Antibody Detection;SARS-CoV-2 Antibody Test;COVID-19 Antibody Test;COVID-19 Antibody Detection;SAR2AB,Quantitative;Ordinal,The determination of the amount of severe acute respiratory syndrome coronavirus 2 antibody in a sample.,,,,C117062,C117062,"Measurement, Test or Examination Detail",string,Detection;Antibody Titer
2025-12-16,Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Measurement,C171439,C171439,C171532,Laboratory Tests;Microbiology Tests;Virology Tests;COVID-19 Tests;SARS-CoV-2 Tests,SARS-CoV-2 Antibody Detection;SARS-CoV-2 Antibody Test;COVID-19 Antibody Test;COVID-19 Antibody Detection;SAR2AB,Quantitative;Ordinal,The determination of the amount of severe acute respiratory syndrome coronavirus 2 antibody in a sample.,,,,C82535,C82535,Test Method,string,Immunofluorescence
2025-12-16,Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Measurement,C171439,C171439,C171532,Laboratory Tests;Microbiology Tests;Virology Tests;COVID-19 Tests;SARS-CoV-2 Tests,SARS-CoV-2 Antibody Detection;SARS-CoV-2 Antibody Test;COVID-19 Antibody Test;COVID-19 Antibody Detection;SAR2AB,Quantitative;Ordinal,The determination of the amount of severe acute respiratory syndrome coronavirus 2 antibody in a sample.,,,,C70856,C70856,Observation Result,string,Positive;Negative
2025-12-16,Severe Acute Respiratory Syndrome Coronavirus 2 Measurement,C171532,C171532,C171456,Laboratory Tests;Microbiology Tests;Virology Tests;COVID-19 Tests;SARS-CoV-2 Tests,SARSCOV2;SARS-CoV-2 Infection;COVID-19 Infection,Ordinal,The determination of the amount of severe acute respiratory syndrome coronavirus 2 in a sample.,,,,C82535,C82535,Test Method,string,Quantitative Reverse Transcriptase Polymerase Chain Reaction
2025-12-16,Severe Acute Respiratory Syndrome Coronavirus 2 Measurement,C171532,C171532,C171456,Laboratory Tests;Microbiology Tests;Virology Tests;COVID-19 Tests;SARS-CoV-2 Tests,SARSCOV2;SARS-CoV-2 Infection;COVID-19 Infection,Ordinal,The determination of the amount of severe acute respiratory syndrome coronavirus 2 in a sample.,,,,C171435,C171435,Specimen Anatomic Site,string,Nasopharynx;Throat;Alveolus
2025-12-16,Severe Acute Respiratory Syndrome Coronavirus 2 Measurement,C171532,C171532,C171456,Laboratory Tests;Microbiology Tests;Virology Tests;COVID-19 Tests;SARS-CoV-2 Tests,SARSCOV2;SARS-CoV-2 Infection;COVID-19 Infection,Ordinal,The determination of the amount of severe acute respiratory syndrome coronavirus 2 in a sample.,,,,C70856,C70856,Observation Result,string,Positive;Negative
2025-12-16,Severe Acute Respiratory Syndrome Coronavirus 2 Measurement,C171532,C171532,C171456,Laboratory Tests;Microbiology Tests;Virology Tests;COVID-19 Tests;SARS-CoV-2 Tests,SARSCOV2;SARS-CoV-2 Infection;COVID-19 Infection,Ordinal,The determination of the amount of severe acute respiratory syndrome coronavirus 2 in a sample.,,,,C70700,C70700,Biospecimen Collection Method,string,Swab;Lavage
2025-12-16,Severe Acute Respiratory Syndrome Coronavirus 2 Measurement,C171532,C171532,C171456,Laboratory Tests;Microbiology Tests;Virology Tests;COVID-19 Tests;SARS-CoV-2 Tests,SARSCOV2;SARS-CoV-2 Infection;COVID-19 Infection,Ordinal,The determination of the amount of severe acute respiratory syndrome coronavirus 2 in a sample.,,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Severe Acute Respiratory Syndrome Coronavirus 2 Measurement,C171532,C171532,C171456,Laboratory Tests;Microbiology Tests;Virology Tests;COVID-19 Tests;SARS-CoV-2 Tests,SARSCOV2;SARS-CoV-2 Infection;COVID-19 Infection,Ordinal,The determination of the amount of severe acute respiratory syndrome coronavirus 2 in a sample.,,,,C70713,C70713,Biospecimen Type,string,Endotrachial Fluid;Swabbed Material;Lavage Fluid;Blood;Serum;Sputum
2025-12-16,Severe Acute Respiratory Syndrome Coronavirus 2 Measurement,C171532,C171532,C171456,Laboratory Tests;Microbiology Tests;Virology Tests;COVID-19 Tests;SARS-CoV-2 Tests,SARSCOV2;SARS-CoV-2 Infection;COVID-19 Infection,Ordinal,The determination of the amount of severe acute respiratory syndrome coronavirus 2 in a sample.,,,,C117062,C117062,"Measurement, Test or Examination Detail",string,Detection
2025-12-16,Study Data Tabulation Model Implementation Guide Version,C156604,C156604,C25714,Clinical Trial Attribute;Trial Summary,SDTIGVER;SDTM IG Version;SDTM Implementation Guide Version;SDTMIG Version,Nominal,The version of the CDISC Study Data Tabulation Model implementation guide that is being used in the study submission.,,,,C117460,C117460,Trial Summary Parameter Name of the Reference Terminology,string,CDISC CT
2025-12-16,Study Data Tabulation Model Implementation Guide Version,C156604,C156604,C25714,Clinical Trial Attribute;Trial Summary,SDTIGVER;SDTM IG Version;SDTM Implementation Guide Version;SDTMIG Version,Nominal,The version of the CDISC Study Data Tabulation Model implementation guide that is being used in the study submission.,,,,C117458,C117458,Trial Summary Parameter Value Code,string,C161436l C161437;C161438
2025-12-16,Study Data Tabulation Model Implementation Guide Version,C156604,C156604,C25714,Clinical Trial Attribute;Trial Summary,SDTIGVER;SDTM IG Version;SDTM Implementation Guide Version;SDTMIG Version,Nominal,The version of the CDISC Study Data Tabulation Model implementation guide that is being used in the study submission.,,,,C83447,C83447,Trial Summary Parameter Value,string,3.2;3.3;3.4
2025-12-16,Study Data Tabulation Model Implementation Guide Version,C156604,C156604,C25714,Clinical Trial Attribute;Trial Summary,SDTIGVER;SDTM IG Version;SDTM Implementation Guide Version;SDTMIG Version,Nominal,The version of the CDISC Study Data Tabulation Model implementation guide that is being used in the study submission.,,,,C83445,C83445,Trial Summary Parameter Code,string,SDTIGVER
2025-12-16,Study Data Tabulation Model Implementation Guide Version,C156604,C156604,C25714,Clinical Trial Attribute;Trial Summary,SDTIGVER;SDTM IG Version;SDTM Implementation Guide Version;SDTMIG Version,Nominal,The version of the CDISC Study Data Tabulation Model implementation guide that is being used in the study submission.,,,,C49691,C49691,Trial Summary Parameter,string,SDTM IG Version
2025-12-16,Study Data Tabulation Model Implementation Guide Version,C156604,C156604,C25714,Clinical Trial Attribute;Trial Summary,SDTIGVER;SDTM IG Version;SDTM Implementation Guide Version;SDTMIG Version,Nominal,The version of the CDISC Study Data Tabulation Model implementation guide that is being used in the study submission.,,,,C117461,C117461,Trial Summary Parameter Version of the Reference Terminology,string,2024-09-27
2025-12-16,Systolic Blood Pressure,C25298,C25298,C54706,Vital Signs;Blood Pressure,SYSBP,Quantitative,The maximum pressure exerted into the systemic arterial circulation during the contraction of the left ventricle of the heart.,http://loinc.org/,LOINC,8480-6,C82535,C82535,Test Method,string,Auscultation automatic;Auscultation manual;Cuff-manual palpated;Doppler;Oscillometry;Arterial line;Venous line;Continuous noninvasive arterial pressure (CNAP)
2025-12-16,Systolic Blood Pressure,C25298,C25298,C54706,Vital Signs;Blood Pressure,SYSBP,Quantitative,The maximum pressure exerted into the systemic arterial circulation during the contraction of the left ventricle of the heart.,http://loinc.org/,LOINC,8480-6,C62164,C62164,Body Position,string,"Decubitus;Fowlers;Lateral Decubitus;Left Lateral Decubitus;Prone;Reverse Trendelenburg;Right Lateral Decubitus;Semi-Fowlers;Semi-Recumbent;Sitting;Sitting, Legs Dependent;Sling;Standing;Standing, Bent Forward;Supine;Trendelenburg;Unconstrained"
2025-12-16,Systolic Blood Pressure,C25298,C25298,C54706,Vital Signs;Blood Pressure,SYSBP,Quantitative,The maximum pressure exerted into the systemic arterial circulation during the contraction of the left ventricle of the heart.,http://loinc.org/,LOINC,8480-6,C70856,C70856,Observation Result,decimal,
2025-12-16,Systolic Blood Pressure,C25298,C25298,C54706,Vital Signs;Blood Pressure,SYSBP,Quantitative,The maximum pressure exerted into the systemic arterial circulation during the contraction of the left ventricle of the heart.,http://loinc.org/,LOINC,8480-6,C49669,C49669,Unit of Pressure,string,cmHg;mmHG;Pascal
2025-12-16,Systolic Blood Pressure,C25298,C25298,C54706,Vital Signs;Blood Pressure,SYSBP,Quantitative,The maximum pressure exerted into the systemic arterial circulation during the contraction of the left ventricle of the heart.,http://loinc.org/,LOINC,8480-6,C25185,C25185,Laterality,string,Left;Right
2025-12-16,Systolic Blood Pressure,C25298,C25298,C54706,Vital Signs;Blood Pressure,SYSBP,Quantitative,The maximum pressure exerted into the systemic arterial circulation during the contraction of the left ventricle of the heart.,http://loinc.org/,LOINC,8480-6,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Systolic Blood Pressure,C25298,C25298,C54706,Vital Signs;Blood Pressure,SYSBP,Quantitative,The maximum pressure exerted into the systemic arterial circulation during the contraction of the left ventricle of the heart.,http://loinc.org/,LOINC,8480-6,C13717,C13717,Anatomic Site,string,Arm;Forearm;Thigh;Calf;Artery;Vein
2025-12-16,Treponema pallidum Measurement,C184647,C184647,C154812,Laboratory Tests;Microbiology Tests;Serology Tests;Gram Negative Bacteria Measurements,TPA,Ordinal,The determination of the amount of Treponema pallidum in a biological sample.,,,,C82535,C82535,Test Method,string,Immunofluorescence
2025-12-16,Treponema pallidum Measurement,C184647,C184647,C154812,Laboratory Tests;Microbiology Tests;Serology Tests;Gram Negative Bacteria Measurements,TPA,Ordinal,The determination of the amount of Treponema pallidum in a biological sample.,,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Treponema pallidum Measurement,C184647,C184647,C154812,Laboratory Tests;Microbiology Tests;Serology Tests;Gram Negative Bacteria Measurements,TPA,Ordinal,The determination of the amount of Treponema pallidum in a biological sample.,,,,C70713,C70713,Biospecimen Type,string,Blood;Serum;Urine;Cerebrospinal Fluid;Body Fluid;Swabbed Material
2025-12-16,Treponema pallidum Measurement,C184647,C184647,C154812,Laboratory Tests;Microbiology Tests;Serology Tests;Gram Negative Bacteria Measurements,TPA,Ordinal,The determination of the amount of Treponema pallidum in a biological sample.,,,,C117062,C117062,"Measurement, Test or Examination Detail",string,Detection
2025-12-16,Treponema pallidum Measurement,C184647,C184647,C154812,Laboratory Tests;Microbiology Tests;Serology Tests;Gram Negative Bacteria Measurements,TPA,Ordinal,The determination of the amount of Treponema pallidum in a biological sample.,,,,C70856,C70856,Observation Result,string,
2025-12-16,Troponin I Measurement,C74749,C74749,C111327,Laboratory Tests;Chemistry Tests;Protein or Enzyme Type Measurements;Troponin Measurements,TROPONI,Quantitative;Ordinal,The determination of the amount of troponin I present in a blood sample.,,,,C64571,C64571,Unit of Mass Concentration,string,ug/L;ng/L
2025-12-16,Troponin I Measurement,C74749,C74749,C111327,Laboratory Tests;Chemistry Tests;Protein or Enzyme Type Measurements;Troponin Measurements,TROPONI,Quantitative;Ordinal,The determination of the amount of troponin I present in a blood sample.,,,,C70856,C70856,Observation Result,string,
2025-12-16,Troponin I Measurement,C74749,C74749,C111327,Laboratory Tests;Chemistry Tests;Protein or Enzyme Type Measurements;Troponin Measurements,TROPONI,Quantitative;Ordinal,The determination of the amount of troponin I present in a blood sample.,,,,C93566,C93566,Fasting Status Indicator,boolean,
2025-12-16,Troponin I Measurement,C74749,C74749,C111327,Laboratory Tests;Chemistry Tests;Protein or Enzyme Type Measurements;Troponin Measurements,TROPONI,Quantitative;Ordinal,The determination of the amount of troponin I present in a blood sample.,,,,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Troponin I Measurement,C74749,C74749,C111327,Laboratory Tests;Chemistry Tests;Protein or Enzyme Type Measurements;Troponin Measurements,TROPONI,Quantitative;Ordinal,The determination of the amount of troponin I present in a blood sample.,,,,C70713,C70713,Biospecimen Type,string,Blood;Plasma;Serum
2025-12-16,Troponin Measurement,C111327,C111327,C64430,Laboratory Tests;Chemistry Tests;Protein or Enzyme Type Measurements,Troponin,,The determination of the amount of total troponin present in a sample.,,,,,,,,
2025-12-16,Urine Glucose Test Strip Measurement [RETIRED],NEW_1,,C147905,Laboratory Tests,Urine Glucose Dipstick,Ordinal,An ordinal measurement of glucose present in a sample. [RETIRED],http://loinc.org/,LOINC,2349-9,C70856,C70856,Observation Result,string,
2025-12-16,Urine Glucose Test Strip Measurement [RETIRED],NEW_1,,C147905,Laboratory Tests,Urine Glucose Dipstick,Ordinal,An ordinal measurement of glucose present in a sample. [RETIRED],http://loinc.org/,LOINC,2349-9,C93566,C93566,Fasting Status Indicator,boolean,
2025-12-16,Urine Glucose Test Strip Measurement [RETIRED],NEW_1,,C147905,Laboratory Tests,Urine Glucose Dipstick,Ordinal,An ordinal measurement of glucose present in a sample. [RETIRED],http://loinc.org/,LOINC,2349-9,C70713,C70713,Biospecimen Type,string,Urine
2025-12-16,Urine Glucose Test Strip Measurement [RETIRED],NEW_1,,C147905,Laboratory Tests,Urine Glucose Dipstick,Ordinal,An ordinal measurement of glucose present in a sample. [RETIRED],http://loinc.org/,LOINC,2349-9,C82535,C82535,Test Method,string,Test Strip;Dipstick
2025-12-16,Waist Circumference,C100948,C100948,,Vital Signs;Body Measurements,WSTCIR,Quantitative,"A circumferential measurement of the waist, which may be classified as the area immediately below the lowest rib, at the narrowest part of the torso, midpoint between the lowest rib and the iliac crest, or immediately above the iliac crest.",http://loinc.org/,LOINC,56115-9,C82515,C82515,Collection Date Time,datetime,
2025-12-16,Waist Circumference,C100948,C100948,,Vital Signs;Body Measurements,WSTCIR,Quantitative,"A circumferential measurement of the waist, which may be classified as the area immediately below the lowest rib, at the narrowest part of the torso, midpoint between the lowest rib and the iliac crest, or immediately above the iliac crest.",http://loinc.org/,LOINC,56115-9,C13717,C13717,Anatomic Site,string,Waist
2025-12-16,Waist Circumference,C100948,C100948,,Vital Signs;Body Measurements,WSTCIR,Quantitative,"A circumferential measurement of the waist, which may be classified as the area immediately below the lowest rib, at the narrowest part of the torso, midpoint between the lowest rib and the iliac crest, or immediately above the iliac crest.",http://loinc.org/,LOINC,56115-9,C42578,C42578,Unit of Length,string,cm;in;mm
2025-12-16,Waist Circumference,C100948,C100948,,Vital Signs;Body Measurements,WSTCIR,Quantitative,"A circumferential measurement of the waist, which may be classified as the area immediately below the lowest rib, at the narrowest part of the torso, midpoint between the lowest rib and the iliac crest, or immediately above the iliac crest.",http://loinc.org/,LOINC,56115-9,C70856,C70856,Observation Result,decimal,
